AzTrials
AzTrials

Thoracotomy SurgeryPhase 2BPV échoguidéNCT01842698

Ultrasound-guided PVB

A Phase 2 study testing ultrasoundguided paravertebral catheter in people with Thoracotomy Surgery and Anesthesia, run by Centre Jean Perrin at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Thoracotomy, is a surgical procedure performed routinely in connection with pulmonary surgery. Pain induced by thoracotomy is considered as the most severe post-operative pain. Control of the pain is essential in the perioperative management. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
ultrasoundguided paravertebral catheter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
Apr 2013to Dec 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing programmed lateral or posterolateral thoracotomy, regardless of indication,
  • Aged 18 to 80 years

Who cannot join

  • Surgery performed in the emergency;
  • Specific clinical contexts including neoplasia in terminal phase or palliative phase;
  • Contraindications to the products of the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre de lautte contre le cancer - Centre Jean Perrin

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Feasibility of the Use of Ultrasound-guided Paravertebral Catheterisation for the Analgesic Management of Thoracotomy

Thoracotomy, is a surgical procedure performed routinely in connection with pulmonary surgery. Pain induced by thoracotomy is considered as the most severe post-operative pain. Control of the pain is essential in the perioperative management.

Nowadays, there are several strategies to support this pain, including regional anesthesia techniques in the context of multimodal analgesia. Epidural analgesia reduces pain scores and respiratory complications significantly. ParaVertebral Block (PVB) is a technique as effective as epidural analgesia in the treatment of pain after thoracotomy and could present a more limited number of complications. However, there is no consensus on the best technique for realisation of PVB.

Read more

Para-vertebral catheterisation can be performed by posterior approach in seeking a strength loss after bone contact of transverse vertebral process using the technique of Eason and Wyatt, but it is a blind technique. The ultrasonographic control, developed in the context of all puncture invasive actions, is an effective contribution to the realisation of a BPV, but still insufficiently validated. First used to measure the distance skin - posterior costo-transverse ligament and skin - parietal pleura before procedure, the ultrasonography has recently led to the publication of echo-guided techniques combining recognition of structures defining the space para- vertebral, viewing the progression of the needle and the spread of the local anesthetic. The handling of the ultrasonographic probe associated with the puncture requires additional learning.

The objective of this project is to study the feasibility of para-vertebral catheter insertion under ultrasonographic control. The appearance like "pigtail" of the catheter, the most recently proposed, seems the more attractive in terms of safety. The aim of this pilot prospective study is accurately quantify all qualitative parameters related to the technique in order to achieve a future validation with a medico-economic component.

Ultrasound-guided technique will correspond to a technique with a puncture of the lateral to medial space described by Shibata, after spotting of the first rib proposed by Bouzinac.

This study will be proposed to patients undergoing thoracotomy for total or partial pulmonary resection in Thoracic Surgery service of Centre Jean Perrin, the number of patients required is 60 patients over a period of inclusion of 12 months.

Read the detailed description

Prospective followed of cohort including consecutive patients, all receiving the same technique of anesthesia and analgesia:

  • Preoperative para-vertebral catheterisation on the surgery side.
  • Preoperative test of the efficiency of para-vertebral block.
  • Conventional general anesthesia.
  • Conventional rescue postoperative analgesia.
  • Systematic radiographic control with injection of contrast product into the para-vertebral catheter.
  • Conventional postoperative monitoring.
Being tested
ultrasoundguided paravertebral catheter
Keywords
Thoracotomy surgery, Anesthesia, Ultrasound-guided PVB, Post-operative pain
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasoundguided paravertebral catheterDevice

    Also called ultrasound-guided paravertebral catheterisation

Study groups in NCT01842698
Study groupRoleWhat they receive
ultrasoundguided paravertebral catheterExperimentalultrasoundguided paravertebral catheter
Receives: Device: ultrasoundguided paravertebral catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The overall failure rate of the para-vertebral block

    The overall failure rate of the para-vertebral block ( failed installation or efficiency)

    Measured: 24 hours

Secondary outcomes (5)
  1. The time (in minutes) between the start of the installation and the effective para-vertebral block obtaining

    Effective para-vertebral block obtaining

    Measured: 24 hours

  2. Paravertebral block catheterisation

    •Paravertebral catheterisation efficiency

    Measured: 24 hours

  3. Paravertebral block efficiency

    Paravertebral block efficiency

    Measured: 24 hours

  4. Pain evaluation

    •Pain evaluation with Analogic Visual Scale

    Measured: H0+30 min, +1h, +1h30, +2h, +4h, +8h, +12h, +16h, +20h, +24h, +32h, +40h, +48h

  5. Tolerance hemodynamic, nausea and vomiting

    Tolerance hemodynamic, nausea and vomiting reporting

    Measured: 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionDec 2013
  4. Study completionDec 2013

Why it stopped: The study was stopped because there was a technical problem with the ultrasound used in the trial.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01842698
Sponsor's protocol ID
BPVéchoguidé
Acronym
BPV échoguidé
Status last verified
Mar 2014
First submitted
14 Feb 2013
Last updated
20 Mar 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing ultrasoundguided paravertebral catheter in people with Thoracotomy Surgery and Anesthesia, run by Centre Jean Perrin at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: The study was stopped because there was a technical problem with the ultrasound used in the trial.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The overall failure rate of the para-vertebral block (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in